Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 3.3mm NC, SLA? 10mm, Ti, Loxim: medical device reports filed with FDA

3,296 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

3,296
device reports naming the brand
0% of all MAUDE reports · about 483 a year
620
reports, 12 months to August 2026
766 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

3,296 medical device reports received by FDA name the brand "BL, ? 3.3mm NC, SLA? 10mm, Ti, Loxim" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

620 reports arrived in the 12 months to August 2026, down 19% from 766 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (88.8%), loss of osseointegration (9.3%) and fracture (1.2%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

097193Sep 2021: 11Oct 2021: 30Nov 2021: 18Dec 2021: 232022Jan 2022: 22Feb 2022: 14Mar 2022: 25Apr 2022: 13May 2022: 21Jun 2022: 15Jul 2022: 21Aug 2022: 11Sep 2022: 17Oct 2022: 45Nov 2022: 44Dec 2022: 372023Jan 2023: 26Feb 2023: 12Mar 2023: 26Apr 2023: 41May 2023: 59Jun 2023: 57Jul 2023: 77Aug 2023: 75Sep 2023: 63Oct 2023: 58Nov 2023: 97Dec 2023: 722024Jan 2024: 67Feb 2024: 73Mar 2024: 55Apr 2024: 73May 2024: 89Jun 2024: 86Jul 2024: 64Aug 2024: 46Sep 2024: 83Oct 2024: 36Nov 2024: 58Dec 2024: 682025Jan 2025: 54Feb 2025: 31Mar 2025: 73Apr 2025: 47May 2025: 0Jun 2025: 193Jul 2025: 50Aug 2025: 73Sep 2025: 86Oct 2025: 56Nov 2025: 63Dec 2025: 602026Jan 2026: 48Feb 2026: 42Mar 2026: 31Apr 2026: 51May 2026: 38Jun 2026: 46Jul 2026: 58Aug 2026: 41

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03997982019: 9420192020: 11220202021: 20320212022: 28520222023: 66320232024: 79820242025: 78620252026: 3552026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%3,296
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report98.5%3,247
Voluntary report0%0
User facility report0%0
Distributor report1.5%49
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate2,92788.8%62.8%
Loss of osseointegration3059.3%22.4%
Fracturea broken bone391.2%1.6%
Difficult to insertthe device was hard to insert60.2%0.4%
Unintended movement30.1%0%
Separation failure20.1%0.1%
Unstable10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis45813.9%
Painpain, site not specified2597.9%
Inflammationinflammation2517.6%
Tissue damage1374.2%
Swelling/ edema1043.2%
Hemorrhage/blood loss/bleeding942.9%
Numbnessnumbness341%
Fistula290.9%
Abscessa collection of pus260.8%
Failure of implant70.2%
Hyperresponsive to stimuli70.2%
Hypersensitivity/allergic reaction60.2%
Sinus perforation40.1%
Swellingswelling30.1%
Inadequate osseointegration10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 3.3mm NC, SLA? 10mm, Ti, LoximProduct code DZEAll MAUDE reports
Reports3,2963,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer98.5%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 3.3mm NC, SLA? 10mm, Ti, Loxim reports

How many FDA reports name BL, ? 3.3mm NC, SLA? 10mm, Ti, Loxim?

3,296 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 620 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (88.8%), loss of osseointegration (9.3%), fracture (1.2%), difficult to insert (0.2%) and unintended movement (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (98.5%) and distributor reports (1.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 3.3mm NC, SLA? 10mm, Ti, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.